Loading company…
Subsense develops non-surgical brain-computer interfaces using biocompatible nanoparticles.
Subsense develops bidirectional brain-computer interfaces intended to record and stimulate neural activity using biocompatible nanoparticles. The technology targets people with paralysis and neurological disorders and is also intended for diagnostics and human-machine interaction. Founded in 2022, the company is based in Covina, US. In December 2025, it raised USD 10.00 mn in Seed funding from Golden Falcon Aviation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in